Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease
Authors
Keywords
COPD, Budesonide/formoterol, Exacerbation, Reliever medication, Predictor
Journal
BMC Pulmonary Medicine
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-08-20
DOI
10.1186/s12890-015-0077-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A score to predict short-term risk of COPD exacerbations (SCOPEX)
- (2015) Barry Make et al. International Journal of Chronic Obstructive Pulmonary Disease
- Population-Based Burden of COPD-Related Visits in the ED
- (2013) Karin B. Yeatts et al. CHEST
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
- (2012) Jørgen Vestbo et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Asthma Control Test (ACT): Comparison with Clinical, Functional, and Biological Markers of Asthma Control
- (2012) Lorenza Melosini et al. JOURNAL OF ASTHMA
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Theo Vos et al. LANCET
- The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy
- (2012) Roland Buhl et al. RESPIRATORY RESEARCH
- Efficacy of Aclidinium Bromide 400 μg Twice Daily Compared With Placebo and Tiotropium in Patients With Moderate to Severe COPD
- (2011) Rainard Fuhr et al. CHEST
- Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
- (2011) Claus Vogelmeier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study
- (2011) Amir Sharafkhaneh et al. RESPIRATORY MEDICINE
- A new perspective on optimal care for patients with COPD
- (2011) Dirkje Postma et al. Primary Care Respiratory Journal
- Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease
- (2010) James F. Donohue et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Symptom variability in patients with severe COPD: a pan-European cross-sectional study
- (2010) R. Kessler et al. EUROPEAN RESPIRATORY JOURNAL
- Overall asthma control: The relationship between current control and future risk
- (2010) Eric D. Bateman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
- (2009) Tobias Welte et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease
- (2009) Stephen I. Rennard et al. DRUGS
- Efficacy and Safety of Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- (2008) Donald P Tashkin et al. DRUGS
- Outcomes for COPD pharmacological trials: from lung function to biomarkers
- (2008) M. Cazzola et al. EUROPEAN RESPIRATORY JOURNAL
- Patients may respond differently to paper and electronic versions of the same questionnaires
- (2008) Elizabeth F. Juniper et al. RESPIRATORY MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More